Showing results (41-50 of 420) with videos related to
Sort By:
Pageof 42
European Journal of Clinical Pharmacology|January 1, 1987
Absence of a clinically significant interaction between theophylline and furosemideU A Jänicke, B Krüdewagen, A Schulz, et al.Toxicology Letters|April 27, 2001
The use of toxicodynamics in risk assessmentB Heinrich-Hirsch, S Madle, A Oberemm, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1994
Fenoterol metabolism in man: sulphation versus glucuronidationR Hildebrandt, B Wagner, K Preiss-Nowzohour, et al.Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1983
The pharmacokinetics of furazlocillin in healthy humansP H Hinderling, U Gundert-Remy, D Förster, et al.International Journal of Clinical Pharmacology and Therapeutics|July 1, 1995
Biliary excretion of mezlocillin in patients with hepatic diseaseR Hildebrandt, U Gundert-Remy, R Raedsch, et al.Hepatology (Baltimore, Md.)|May 1, 1985
Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patientsA Stiehl, R Raedsch, G Rudolph, et al.European Journal of Clinical Pharmacology|January 1, 1984
Correlation between the pharmacokinetics and pharmacodynamics of dopamine in healthy subjectsU Gundert-Remy, J Penzien, R Hildebrandt, et al.Acta Anaesthesiologica Scandinavica|September 1, 1996
Pharmacokinetics of piritramide after an intravenous bolus in surgical patientsD Kietzmann, I Briede, T Bouillon, et al.European Journal of Clinical Pharmacology|January 1, 1992
The pharmacokinetics of the beta 2-adrenoceptor agonist fenoterol in healthy womenK Warnke, R Hildebrandt, K Günther, et al.Zeitschrift Fur Gerontologie|March 1, 1981
[Cerebrovascular insufficiency and compliance with drug therapy]B Fischer, S Lehrl, E Weber, et al.Pageof 42